Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 313 of the 313 references it cites were found in a registry or an index.

From NASH to HCC: current concepts and future challenges

Open access
Anstee, Quentin M., Reeves, Helen L., Kotsiliti, Elena, Govaere, Olivier, Heikenwalder, Mathias · 2019 · Nature Reviews Gastroenterology & Hepatology

Abstract

Caloric excess and sedentary lifestyle have led to a global epidemic of obesity and metabolic syndrome. The hepatic consequence of metabolic syndrome and obesity, nonalcoholic fatty liver disease (NAFLD), is estimated to affect up to one-third of the adult population in many developed and developing countries. This spectrum of liver disease ranges from simple steatosis to nonalcoholic steatohepatitis (NASH) and cirrhosis. Owing to the high prevalence of NAFLD, especially in industrialized countries but also worldwide, and the consequent burden of progressive liver disease, there is mounting epidemiological evidence that NAFLD has rapidly become a leading aetiology underlying many cases of hepatocellular carcinoma (HCC). In this Review, we discuss NAFLD-associated HCC, including its epidemiology, the key features of the hepatic NAFLD microenvironment (for instance, adaptive and innate immune responses) that promote hepatocarcinogenesis and the management of HCC in patients with obesity and associated metabolic comorbidities. The challenges and future directions of research will also be discussed, including clinically relevant biomarkers for early detection, treatment stratification and monitoring as well as approaches to therapies for both prevention and treatment in those at risk or presenting with NAFLD-associated HCC.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41575-019-0145-7

Cites

313 of 313 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

1 retracted

Show all 313 references

Cited by

See all 1,392

Metadata

Authors
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M.
Affiliations
  • Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
  • German Cancer Research Center (DE)
  • Newcastle University (GB)
Corresponding author
Anstee, Quentin M.
Venue
Nature Reviews Gastroenterology & Hepatology
Published
2019-04-26
Volume
16
Issue
7
Pages
411-428
ISSN
  • 1759-5045 (ISSN-L)
  • 1759-5053
OpenAlex
W2941033601
Cited by
1,392
References
313
Citations by year
2026: 119 · 2025: 157 · 2024: 208 · 2023: 240 · 2022: 251 · 2021: 236 · 2020: 148 · 2019: 32
FWCI
21.91
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Lirias (KU Leuven) (submittedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
Cancer Research UK (26813, 23390)
Topics
  • Health Sciences › Medicine › Hepatology › Hepatocellular Carcinoma Treatment and Prognosis
  • Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords
non-alcoholic fatty liver disease, hepatocellular carcinoma, nonalcoholic steatohepatitis, obesity, metabolic syndrome, hepatocarcinogenesis, liver microenvironment, immune response, biomarkers, early detection, liver cirrhosis
MeSH terms
Carcinoma, Hepatocellular, Humans, Liver, Liver Neoplasms, Morbidity, Risk Factors, Global Health, Disease Progression, Tumor Microenvironment, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: From NASH to HCC: current concepts and future challenges. https://app.cochat.ai/papers/10.1038/s41575-019-0145-7
The paper
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019). From NASH to HCC: current concepts and future challenges. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-019-0145-7

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.